Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioMarin Pharmaceutical

BioMarin Pharmaceutical?uq=hBqTzBbB
PUBLIC STATUS
1K-5K EMPLOYEES
BMRN STOCK SYMBOL
13 INVESTMENTS
$94.51 SHARE PRICE (As of Wednesday Closing)
Description

Developer of bio pharmaceuticals for serious diseases and medical conditions intended to serve the needs of patients, families, and physicians. The company provides rapid access to therapeutic treatment, disease education, and support services, enabling patients and doctors across the world access to therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase and therapeutics for phenylketonuria.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 105 Digital Drive
  • Novato, CA 94949
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioMarin Pharmaceutical’s full profile, request a free trial.

BioMarin Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$76.01 - $106.07 $16.4B $92.34 -$0.71 1.15M 178M

BioMarin Pharmaceutical Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 17,049,489 15,569,086 13,888,229 16,970,931
Revenue 1,496,303 1,313,646 1,116,854 889,895
EBITDA 76,609 76,115 (705,493) (77,088)
Net Income (124,953) (117,042) (630,210) (171,799)
Total Assets 4,695,254 4,633,125 4,023,690 3,729,368
Total Debt 1,200,349 1,174,470 683,239 662,286
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioMarin Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioMarin Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

BioMarin Pharmaceutical Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000 & 000 01-Oct-2015 000000000 00000 00 00000 Other Business Products and Services 0000-0000000 00000000
00000000 29-Jan-2015 000000000000000000 00000 Biotechnology 0000-0000000 00000000
00000000 000000000 07-Jan-2013 000000000000000000 00000 Pharmaceuticals
000000 (000000000 01-Aug-2011 000000000 00000 00 000.00 Buildings and Property 0000-0000000 00000000
ZyStor Therapeutics 17-Aug-2010 Merger/Acquisition 00000 Biotechnology 0000-0000000 00000000
To view this company’s complete investment and acquisition history, request access »

BioMarin Pharmaceutical Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 00000 000000000 16-Jan-2009 0000 00.00 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

BioMarin Pharmaceutical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BioMarin Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

BioMarin Pharmaceutical Executive Team (19)

Name Title Board
Seat
Contact
Info
Jean-Jacques Bienaime Chief Executive Officer & Chairman
Henry Fuchs MD President, Worldwide Research & Development
Daniel Spiegelman Chief Financial Officer & Executive Vice President
Philip Lo Scalzo JD Senior Vice President & Chief Compliance Officer
Lon Cardon Ph.D Chief Scientific Officer & Senior Vice President

7 Former Executives

You’re viewing 5 of 19 executives. Get the full list »

BioMarin Pharmaceutical Board Members (14)

Name Representing Role Since Contact
Info
Alan Lewis Ph.D Self Board Member 000 0000
Bryan Lawlis Ph.D Self Board Member 000 0000
Dennis Slamon Ph.D BioMarin Pharmaceutical Board Member 000 0000
Elaine Heron Ph.D Self Board Member 000 0000
Jean-Jacques Bienaime BioMarin Pharmaceutical Chief Executive Officer & Chairman 000 0000

5 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »